EP 1938831 A1 20080702 - Novel exendin agonist compounds
Title (en)
Novel exendin agonist compounds
Title (de)
Neue Exendinagonist-Verbindungen
Title (fr)
Nouveaux composants d'agoniste d'exendine
Publication
Application
Priority
- EP 98939260 A 19980806
- US 5540497 P 19970808
Abstract (en)
Novel exendin agonist compounds are provided. These compounds are useful in treating Type I and II diabetes and conditions which would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying.
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61P 3/10 (2006.01); C07K 14/46 (2006.01); C07K 14/575 (2006.01)
CPC (source: EP)
A61P 3/10 (2017.12); C07K 14/57563 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
- [PX] WO 9805351 A1 19980212 - AMYLIN PHARMACEUTICALS INC [US], et al
- [PX] WO 9830231 A1 19980716 - AMYLIN PHARMACEUTICALS INC [US]
- [X] US 5424286 A 19950613 - ENG JOHN [US]
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
DOCDB simple family (application)
EP 07020414 A 19980806